Your browser doesn't support javascript.
loading
Debridement, antibiotics and implant retention (DAIR) is successful in the management of acutely infected unicompartmental knee arthroplasty: a case series.
Brivio, Angela; Al-Jabri, Talal; Martin, Jurgen; Barrett, David; Maffulli, Nicola.
Afiliación
  • Brivio A; Department of Trauma and Orthopedic Surgery, Istituto Clinico Città Studi, Milano, Italy.
  • Al-Jabri T; King Edward VII's Hospital, London, United Kingdom.
  • Martin J; Trauma and Orthopaedic Surgery, Department of Surgery and Cancer, Imperial College London, United Kingdom.
  • Barrett D; Vulpius Klinik, Bad Rappenau, Germany.
  • Maffulli N; King Edward VII's Hospital, London, United Kingdom.
Ann Med ; 55(1): 680-688, 2023 12.
Article en En | MEDLINE | ID: mdl-37074322
BACKGROUND: Infections are rare and poorly studied complications of unicompartmental knee arthroplasty (UKA) surgery. They are significantly less common compared to infections after total knee arthroplasties (TKAs). Optimal management of periprosthetic joint infections (PJIs) after a UKA is not clearly defined in the literature. This article presents the results of the largest multicentre clinical study of UKA PJIs treated with Debridement, Antibiotics and Implant Retention (DAIR). MATERIALS AND METHODS: In this retrospective case series, patients presenting between January 2016 and December 2019 with early UKA infection were identified at three specialist centres using the Musculoskeletal Infection Society (MSIS) criteria. All patients underwent a standardized treatment protocol consisting of the DAIR procedure and antibiotic therapy comprising two weeks of intravenous (IV) antibiotics followed by six weeks of oral therapy. The main outcome measure was overall survivorship free from reoperation for infection. RESULTS: A total of 3225 UKAs (2793 (86.2%) medial and 432 (13.8%) lateral UKAs) were performed between January 2016 and December 2019. Nineteen patients had early infections necessitating DAIR. The mean follow-up period was 32.5 months. DAIR showed an overall survivorship free from septic reoperation of 84.2%, with overall survivorship free from all-cause reoperation of 78.95%.The most common bacteria were Coagulase-negative Staphylococci, Staphylococcus aureus and Group B Streptococci. Three patients required a second DAIR procedure but remained free from re-infection at follow-up obviating the need for more demanding, staged revision surgery. CONCLUSIONS: In infected UKAs, the DAIR procedure produces a high rate of success, with a high survivorship of the implant.Key messagesDebridement, Antibiotics and Implant Retention (DAIR) is a successful and minimally invasive surgical option for the management of periprosthetic joint infections (PJIs) after UKA.The surface area available for bacteria to colonise is much smaller in UKAs compared to total knee arthroplasties (TKAs), and this may account for the higher success rates of the DAIR procedure in infected UKAs versus infected TKAs.A second DAIR procedure can be considered in the management of the early recurrence of PJIs with a well-fixed UKA.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Infecciosa / Infecciones Relacionadas con Prótesis / Artroplastia de Reemplazo de Rodilla Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Infecciosa / Infecciones Relacionadas con Prótesis / Artroplastia de Reemplazo de Rodilla Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Med Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido